Scalable EEG Solutions for Timely Status Epilepticus Management: From Guideline Targets to Real-World Implementation

Current society guidance (NCS, ACNS, AHA and allied consensus statements) converges on the following evidence-based principles: (a) electroencephalography (EEG) is essential for suspected ongoing SE and for many critically ill patients with depressed or fluctuating consciousness; (b) time to EEG matters, earlier monitoring increases the probability of detecting electrographic seizures that would otherwise be missed and guides safer, more precise treatment; (c) monitoring duration should be individualized but typically extends ≥24 hours after electrographic seizure control; and (d) addressing implementation barriers (technologist availability, device footprint, remote interpretation, and staff training) is necessary to translate guideline recommendations into routine clinical practice. BrainView NeuroTrace’s innovative technology platform uniquely combines high-fidelity EEG acquisition, AIassisted detection, rapid deployment, and cloud-enabled remote monitoring to fill current gaps in access, scalability, and workflow efficiency. This comprehensive approach empowers clinicians to deliver timely, guideline-concordant care across a spectrum of settings, from rural and community hospitals to ambulatory and post–cardiac arrest care. As such, there is an opportunity to profoundly improve patient outcomes, and concomitantly contain costs. Urgent adoption of advanced EEG systems like BrainView NeuroTrace represents a critical step toward transforming SE management and expanding the reach of neurodiagnostic services beyond single-point competitors.